Navigate
X
    QualityStocks
  • 17 years ago

CytRx Corporation (NASDAQ: CYTR)

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company, is focused on developing high-value human therapeutics. Their drug development pipeline includes six programs in clinical development. The Company owns and operates a research and development facility in San Diego, California, and holds a 45% equity interest in RXi Pharmaceuticals (NasdaqCM: RXII ). For further information, visit the Company’s web site at www.cytrx.com.

Tags Rodman & Renshaw
Related Post
  1. QualityStocksNewsBreaks – Powering AI: Nicola Mining Inc.’s (TSX.V: NIM) (OTCQB: HUSIF) Copper Project Aligns with Data Center Surge

    As artificial intelligence (“AI”) continues to revolutionize industries, the infrastructure supporting its growth has become…

  2. Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Breaks Ground on REE Processing Facility, Pioneers Domestic Supply Chain

    The company announced the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria. The…

  3. NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

    The new FDA voucher program aims to speed approval of drugs aligned with national health…